Crossmark

Formulation and Characterization of Nanosized Ethosomal Formulations of Antigout Model Drug (Febuxostat) Prepared by Cold Method: In Vitro/Ex Vivo and In Vivo Assessment

Crossref DOI link: https://doi.org/10.1208/s12249-019-1556-z

Published Online: 2019-12-19

Published Print: 2020-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

El-Shenawy, Ahmed A.

Abdelhafez, Wael A.

Ismail, Ahmed

Kassem, Alaa A.
License Information

Text and Data Mining valid from 2019-12-19

Version of Record valid from 2019-12-19
More Information

Article History

Received: 3 September 2019

Accepted: 6 November 2019

First Online: 19 December 2019

Compliance with Ethical Standards

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below